France’s Faircraft Secures VitroLabs’ Patent Portfolio Through US Asset Acquisition

French biotechnology company Faircraft has acquired key assets from VitroLabs, a California-based firm specializing in the development of lab-grown leather. The acquisition includes a portfolio of 30 patents, positioning Faircraft as a leader in in vitro leather production. Founded in 2021, Faircraft has focused on transitioning lab-grown leather from research to industrial application, with the integration of VitroLabs' scientific advances expected to support this move toward full-scale manufacturing.

Co-founders Haïkel Balti and César Valencia Gallardo bring backgrounds in material science and cellular biology, respectively, positioning Faircraft to develop biomaterials for use in high-end fashion and leather goods. With support from international investors and collaborations with luxury brands, Faircraft plans to establish a full-scale production plant within two years. The company aims to make in vitro leather a mark of prestige for the world's leading fashion houses, reflecting a strategic turning point in their development.